![]() | - SMTL ID
- 9rkc.1
- Ligands
- (2~{S},4~{R})-1-[(2~{S})-2-[(5~{S})-5-[3-[(3~{S})-4-[4-[5-[(4~{S})-2-azanyl-3-cyano-4-methyl-6,7-dihydro-5~{H}-1-benzothiophen-4-yl]-1,2,4-oxadiazol-3-yl]pyrimidin-2-yl]-3-methyl-1,4-diazepan-1-yl]propyl]-4,5,6,7-tetrahydrobenzotriazol-1-yl]-3-methyl-butanoyl]-~{N}-[(1-methylindazol-6-yl)methyl]-4-oxidanyl-pyrrolidine-2-carboxamide; GUANOSINE-5'-DIPHOSPHATE; MAGNESIUM ION
- Polypeptides
- Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor; GTPase KRas
- Oligo-state
- hetero-1-1-1-1-mer
|
![]() | - SMTL ID
- 9rkc.2
- Ligands
- (2~{S},4~{R})-1-[(2~{S})-2-[(5~{S})-5-[3-[(3~{S})-4-[4-[5-[(4~{S})-2-azanyl-3-cyano-4-methyl-6,7-dihydro-5~{H}-1-benzothiophen-4-yl]-1,2,4-oxadiazol-3-yl]pyrimidin-2-yl]-3-methyl-1,4-diazepan-1-yl]propyl]-4,5,6,7-tetrahydrobenzotriazol-1-yl]-3-methyl-butanoyl]-~{N}-[(1-methylindazol-6-yl)methyl]-4-oxidanyl-pyrrolidine-2-carboxamide; GUANOSINE-5'-DIPHOSPHATE; MAGNESIUM ION
- Polypeptides
- Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor; GTPase KRas
- Oligo-state
- hetero-1-1-1-1-mer
|